• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Chris Newmarker

Harvard Apparatus touts pump for brain injections

May 24, 2017 By Chris Newmarker

Harvard Appartus Pump 11 Elite Nanomite

Harvard Apparatus is boasting of the abilities of its Pump 11 Elite Nanomite – a single syringe infusion/withdrawal programmable syringe pump designed for precise point infusion applications. Researchers used the Pump 11 Elite Nanomite to successfully perform injections into specific sub-regions of the caudate nucleus in the brain. They repeatedly injected a 1 mm diameter target in […]

Filed Under: Neurological, Research & Development Tagged With: harvardapparatus

Infertility: There could be a 3D printing solution

May 16, 2017 By Chris Newmarker

New Northwestern University research offers a potential 3D printing solution for women’s infertility – providing hope for cancer survivors who want to start families. The Northwestern researchers successfully 3D printed a bioprosthetic mouse ovary that ovulated when implanted inside a live mouse. Mice with the bioprosthetic ovaries were able to give birth to live pups, […]

Filed Under: Featured, Hydrogels, Implants, Regenerative Medicine, Women's Health Tagged With: 3D printing, bioprinting, infertility, Northwestern University

AdvaMed unveils new tools to assess medical device value

May 15, 2017 By Chris Newmarker

AdvaMed value initiative

AdvaMed today launched a new value initiative that includes extensive tables of questions to help medical device companies formulate value-based arguments. The value framework also includes tools specifically designed for diagnostic technologies, as well as report on understanding evidence and use cases. “Value” has become an important word in medtech in recent years as government and […]

Filed Under: Business/Financial News, Clinical Trials, Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: AdvaMed, value-based care

23andMe is back: FDA allows marketing of genetic health risk tests

April 21, 2017 By Chris Newmarker

23andMe

FDA this month allowed genetic testing company 23andMe to market genetic health risk tests for 10 diseases and conditions including Parkinson’s disease and late-onset Alzheimer’s disease. The de novo premarket review authorization, announced April 6, also included celiac disease, which results in the inability to digest gluten; alpha-1 antitrypsin deficiency, which raises the risk of […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: 23andme, FDA, medtech

How Boston Sci is getting drug-eluting stents and balloons into legs

April 13, 2017 By Chris Newmarker

Boston Scientific officials think they have a leg up when it comes to bringing drug-eluting technology to bear on peripheral artery disease. That’s because the medical device giant has decades of experience with balloons and drug-eluting stents used around the heart. When it comes to treating the narrowing arteries in the legs and thighs, Boston […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Stents, Vascular Tagged With: Boston Scientific, drug-eluting balloons, drug-eluting stents, medtech

What you need to know to make connected medical devices

April 12, 2017 By Chris Newmarker

Bill Welch, Phillips-Medisize The estimated number of connected medical devices – devices connected to the Internet –is expected to increase from 10 billion to 50 billion over the next decade, according to the IBM Institute for Business Value. This is due to the ability for machine-to-machine communication through cloud computing and networks of data-gathering sensors, […]

Filed Under: Drug-Device Combinations, Featured, mHealth (Mobile Health) Tagged With: connectedmedicaldevices, Phillips-Medisize

How the CellMist SkinGun heals: a Q&A with RenovaCare’s CEO

April 5, 2017 By Chris Newmarker

RenovaCare CellMist SkinGun

Heather Thompson, Senior Editor When Thomas Bold joined RenovaCare in 2013, he was already familiar with its potentially groundbreaking technology. Bold had served as StemCell Systems CEO in Berlin for many years. He was involved in the development of the CellMist and SkinGun – the platform technologies for RenovaCare Inc. The technologies represent a shift in thinking about wound care, […]

Filed Under: Drug-Device Combinations, Featured, Stem Cells, Wound Care Tagged With: medtech, RenovaCare, stem cells, wound care

The top medtech stories of early 2017

March 24, 2017 By Chris Newmarker

Donald Trump top medtech stories

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty – is the major story for the medical device industry. But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, diabetes […]

Filed Under: Business/Financial News, Diabetes, Featured, Food & Drug Administration (FDA), Mergers & Acquisitions Tagged With: Abbott Laboratories, Absorb, Affordable Care Act, Diabetes, Donald Trump, Insulet, medtech, Obamacare, Omnipod

Do patient advocacy organizations have a conflict of interest?

March 22, 2017 By Chris Newmarker

money conflict of interest

At least 83% of U.S. patient advocacy organizations receive financial support from medical device, drug and biotechnology companies, according to new research out of the University of Pennsylvania’s Department of Medical Ethics and Health Policy. The Penn research team – which included Matthew McCoy, Harald Schmidt and Ezekiel Emanuel – examined websites and annual reports for 104 organizations […]

Filed Under: Business/Financial News, Featured, Legal News, Patient Monitoring, Preclinical Trials, Research & Development Tagged With: conflict of interest, medtech, National Health Council, patient advocacy organizations, University of Pennsylvania

3D printing is taking medical marijuana to a whole new level

March 15, 2017 By Chris Newmarker

Syqe cannabis inhaler medical marijuana 3D printing

3D printing is aiding an Israel-based company in the development and production of special selective-dose inhalers for medical marijuana and other medicinal plants. Nano Dimension (Ness Ziona, Israel)—which makes 3D printers for printed circuit boards—announced today that it has leased a DragonFly 2020 3D printer to Syqe Medical (Tel Aviv, Israel). Syqe boasts that it has created the […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management Tagged With: 3D printing, medical marijuana, medtech, Nano Dimension, Syqe Medical

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS